Development of High-Content Gemcitabine PEGylated Liposomes and Their Cytotoxicity on Drug-Resistant Pancreatic Tumour Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of High-Content Gemcitabine PEGylated Liposomes and Their Cytotoxicity on Drug-Resistant Pancreatic Tumour Cells
Authors
Keywords
gemcitabine, gemcitabine-resistant pancreatic cancer cells, PEGylated liposome, remote loading, small volume incubation
Journal
PHARMACEUTICAL RESEARCH
Volume 31, Issue 10, Pages 2583-2592
Publisher
Springer Nature
Online
2014-03-18
DOI
10.1007/s11095-014-1353-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations
- (2013) Shyam Bansal et al. CURRENT DRUG TARGETS
- Phase structure of liposome in lipid mixtures
- (2011) Tianxi Zhang et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases
- (2011) D. Cosco et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
- (2010) Kazuo Maruyama ADVANCED DRUG DELIVERY REVIEWS
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
- (2010) Shadan Ali et al. CANCER RESEARCH
- Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity
- (2010) Donatella Paolino et al. JOURNAL OF CONTROLLED RELEASE
- Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)
- (2010) Ryan B. Huang et al. MOLECULAR MEMBRANE BIOLOGY
- In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer
- (2009) Donato Cosco et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice
- (2009) In-Young Kim et al. JOURNAL OF CONTROLLED RELEASE
- Liposome drugs' loading efficiency: A working model based on loading conditions and drug's physicochemical properties
- (2009) Daniel Zucker et al. JOURNAL OF CONTROLLED RELEASE
- Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
- (2009) N. Mylonakis et al. LUNG CANCER
- Antimetastatic Effects of Liposomal Gemcitabine and Empty Liposomes in an Orthotopic Mouse Model of Pancreatic Cancer
- (2009) Ralph Graeser et al. PANCREAS
- Preparation, Optimization, and Characterization of Topotecan Loaded PEGylated Liposomes Using Factorial Design
- (2008) Amir Masoud Vali et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Gemcitabine in the treatment of metastatic pancreatic cancer
- (2008) Andreas Hilbig et al. Expert Review of Anticancer Therapy
- Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: Importance of vascular permeability within tumors
- (2008) Ken-ichi Ogawara et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Improved In Vitro Anti-Tumoral Activity, Intracellular Uptake and Apoptotic Induction of Gemcitabine-Loaded Pegylated Unilamellar Liposomes
- (2008) Christian Celia et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome
- (2007) Ryo Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More